STONKWHISPER
← Back to Intel
Insider ActivityAXSM

Maizel Ari, Chief Commercial Officer at Axsome Therapeutics, Inc., sold $1.4M of AXSM

Updated Jun 14, 2026
Maizel Ari Chief Commercial Officer
Axsome Therapeutics, Inc. · $AXSM
$1.4M Total Value
7,500 Shares Traded
$182.42 Price / Share
Shares Owned After
2026-04-23 Filing Date

Transaction Details

InsiderMaizel Ari
TitleChief Commercial Officer
CompanyAxsome Therapeutics, Inc.
TickerAXSM
Transaction TypeSale
Transaction Date2026-04-22
Shares Traded7,500
Price Per Share$182.42
Total Value$1.4M
Filed Date2026-04-23
Accession Number0001193125-26-174415

Ownership Context

Shares Owned After Transaction
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-174415

Other Insider Trades — AXSM

Other Trades by Maizel Ari

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for AXSM — Axsome Therapeutics, Inc. →

Whisper Score — AXSM

49.61
Active Discussion
Current Whisper Score

See full analysis for AXSM →

Track AXSM insider activity in real time on The Wire →

Get alerts when Maizel Ari files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 14, 2026 at 07:16 UTC

Want real-time data? Access The Wire for live sentiment tracking.